Trial intelligence / Profile preview

Quadrivalent Influenza Vaccine in Children 6 Months to 3 Years

ChiCTR-IIR-16008507Phase 3Recruiting

Sponsor
Hubei Center for Disease Control and Prevention
Start
Oct 2015
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of influenza virus quadrivalent inactivated vaccine in influenza (3 arms), sponsored by Hubei Center for Disease Control and Prevention. Primary endpoint: Adverse reaction rate. Started Oct 2015; status: recruiting.

02

Drugs

influenza virus quadrivalent inactivated vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on ChiCTR-IIR-16008507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-16008507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call